Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment
Yilan Xu, Man-Na Zhao, Yuying Han, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
Kin Yip Tam, Yaojun Ju
Neural Regeneration Research (2021) Vol. 17, Iss. 3, pp. 543-543
Open Access | Times Cited: 254
GABAA receptors: structure, function, pharmacology, and related disorders
Amr Ghit, Dina Assal, Ahmed S. Al‐Shami, et al.
Journal of Genetic Engineering and Biotechnology (2021) Vol. 19, Iss. 1, pp. 123-123
Open Access | Times Cited: 248
Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Jesús Burillo, Patricia Marqués, Beatriz Jiménez, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1236-1236
Open Access | Times Cited: 133
GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease
Joan Jiménez-Baladó, Teal S. Eich
Seminars in Cell and Developmental Biology (2021) Vol. 116, pp. 146-159
Open Access | Times Cited: 128
Advancing cell therapy for neurodegenerative diseases
Sally Temple
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 512-529
Open Access | Times Cited: 90
Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
S. Meftah, Jian Gan
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 70
Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
Zhenqi Yang, Yong Zou, Lifeng Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3841-3841
Open Access | Times Cited: 49
Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ali K. Albuhadily, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 16
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
Sofia Toniolo, Arjune Sen, Masud Husain
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9318-9318
Open Access | Times Cited: 71
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration
Nerea Gómez de San José, Federico Massa, Steffen Halbgebauer, et al.
Journal of Neural Transmission (2021) Vol. 129, Iss. 2, pp. 207-230
Open Access | Times Cited: 57
Stiff person syndrome spectrum disorders; more than meets the eye
Scott D. Newsome, Tory P. Johnson
Journal of Neuroimmunology (2022) Vol. 369, pp. 577915-577915
Open Access | Times Cited: 56
Integrated multi-omics analysis of Alzheimer’s disease shows molecular signatures associated with disease progression and potential therapeutic targets
Pradeep Kodam, R. Sai Swaroop, Sai Sanwid Pradhan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Microglial Activation in Metal Neurotoxicity: Impact in Neurodegenerative Diseases
María I. Martínez-Hernández, Leonor C. Acosta‐Saavedra, Luisa C. Hernández‐Kelly, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 27
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
Christopher D. Morrone, Radha Raghuraman, S. Abid Hussaini, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 27
The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer's disease
Yuanhong Tang, Yan Yan, Jian Mao, et al.
Ageing Research Reviews (2023) Vol. 86, pp. 101865-101865
Closed Access | Times Cited: 22
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 14
The role of the GABAergic system on insomnia
Peeraporn Varinthra, Shameemun Naseer Mohamed Nizarul Anwar, Shu‐Ching Shih, et al.
Tzu Chi Medical Journal (2024) Vol. 36, Iss. 2, pp. 103-109
Open Access | Times Cited: 10
Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus
Karan Govindpani, Clinton Turner, Henry J. Waldvogel, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8704-8704
Open Access | Times Cited: 65
Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease
Olayemi Joseph Olajide, Marcus E. Suvanto, C. Andrew Chapman
Biology Open (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Synaptosome microRNAs regulate synapse functions in Alzheimer’s disease
Subodh Kumar, Erika Orlov, Prashanth Gowda, et al.
npj Genomic Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans
Caitlin S. Latimer, Jade G. Stair, Joshua C. Hincks, et al.
Disease Models & Mechanisms (2022) Vol. 15, Iss. 4
Open Access | Times Cited: 28
Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease
Christopher D. Morrone, Aaron Y. Lai, Jossana Bishay, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer’s disease model
Qiuchen Zhao, Megi Maci, Morgan R. Miller, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 20
A comparative review on the well-studied GAT1 and the understudied BGT-1 in the brain
Manan Bhatt, Laure Gauthier-Manuel, Erika Lazzarin, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 16
Early Detection of Alzheimer’s Disease From Cortical and Hippocampal Local Field Potentials Using an Ensembled Machine Learning Model
Marcos Fabietti, Mufti Mahmud, Ahmad Lotfi, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering (2023) Vol. 31, pp. 2839-2848
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top